| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |